Novel Coronavirus (SARS-CoV-2/COVID-19)

The Centers for Medicare & Medicaid Services announced that it is extending the third quarter 2020 data submission deadlines for several of its quality reporting and value programs for hospitals, post-acute care and other providers.
The Centers for Medicare & Medicaid Services posted additional information to help health care providers implement six new ICD-10 diagnosis codes for reporting conditions related to COVID-19 on medical claims effective Jan. 1. The information includes updated coding guidelines, code…
The Food and Drug Administration authorized a prescription BinaxNOW COVID-19 test for use by patients at home, in partnership with a telehealth service that will take users through the sample collection process and assist in reading and understanding the results.
The AHA released a new edition of the COVID-19 Snapshot, highlighting the critical needs of hospitals and health systems during the deepening public health emergency.
The Centers for Medicare & Medicaid Services (CMS) today announced that it is extending the quarter 3 (Q3) 2020 data submission deadlines for several of its quality reporting and value programs for hospitals, post-acute care and other providers. CMS indicates the extension is intended “to help…
Please join AHA Board Chair Melinda Estes, M.D., for the eleventh in a series of Leadership Rounds — short conversations on a range of key issues Dr. Estes will have with hospital and health system leaders from across the country. Dr. Estes was joined by Rodney F. Hochman, M.D., President and CEO,…
In this conversation, Nancy Foster, Vice President for Quality and Patient Safety Policy, talks with Sonia Perez, Chief Operating Officer, UnidosUS, and Clint Odom, Senior Vice President, Policy & Advocacy, National Urban League and Executive Director, National Urban League’s Washington Bureau…
As a physician, nurse, respiratory therapist, environmental services or food services worker or other health care professional, your example is one of the strongest health resources we have. When you get your COVID-19 vaccine, please consider sharing your story to help others understand the…
Special Bulletin The Food and Drug Administration (FDA) last week granted an emergency use authorization (EUA) to Pfizer, Inc. for its BNT162b2 mRNA COVID-19 vaccine. As you are aware, distribution and administration of the first shipments are well underway across the country.